The DOI matches its Crossref record; 6 of the 10 references it cites were found in a registry or an index.
Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014
Open accessAbstract
The United States is experiencing an epidemic of drug overdose (poisoning) deaths. Since 2000, the rate of deaths from drug overdoses has increased 137%, including a 200% increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). CDC analyzed recent multiple cause-of-death mortality data to examine current trends and characteristics of drug overdose deaths, including the types of opioids associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1-year increase of 6.5%, from 13.8 per 100,000 persons in 2013 to 14.7 per 100,000 persons in 2014. The rate of drug overdose deaths increased significantly for both sexes, persons aged 25-44 years and ≥55 years, non-Hispanic whites and non-Hispanic blacks, and in the Northeastern, Midwestern, and Southern regions of the United States. Rates of opioid overdose deaths also increased significantly, from 7.9 per 100,000 in 2013 to 9.0 per 100,000 in 2014, a 14% increase. Historically, CDC has programmatically characterized all opioid pain reliever deaths (natural and semisynthetic opioids, methadone, and other synthetic opioids) as "prescription" opioid overdoses (1). Between 2013 and 2014, the age-adjusted rate of death involving methadone remained unchanged; however, the age-adjusted rate of death involving natural and semisynthetic opioid pain relievers, heroin, and synthetic opioids, other than methadone (e.g., fentanyl) increased 9%, 26%, and 80%, respectively. The sharp increase in deaths involving synthetic opioids, other than methadone, in 2014 coincided with law enforcement reports of increased availability of illicitly manufactured fentanyl, a synthetic opioid; however, illicitly manufactured fentanyl cannot be distinguished from prescription fentanyl in death certificate data. These findings indicate that the opioid overdose epidemic is worsening. There is a need for continued action to prevent opioid abuse, dependence, and death, improve treatment capacity for opioid use disorders, and reduce the supply of illicit opioids, particularly heroin and illicit fentanyl.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Opioids accounted for 61% of all drug-related overdoses in 2014 (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
In the citing paper
“Between 2000 and 2014, nearly a half million people in the US died from a drug overdose (1).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [1]
Citations
Cites
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,350
The Changing Face of Heroin Use in the United States
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,169
Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic
Volkow, N. D., Frieden, T. R., Hyde, P. S., & Cha, S. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1402780 · Cited by 1,014
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
Jones, C. M., Logan, J. E., Gladden, R. M., & Bohm, M. K. (2015) · PubMed Central · Cited by 476
Injury in the United States; 2007 chartbook
Bergen, G., Chen, L., & Warner, M. (2008) · Cited by 120
Davis, G. G. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0323-x · Cited by 99
Cited by
Sorted by citations
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Self-citationOpioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,366
Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures
Hill, M. V., McMahon, M. L., Stucke, R. S., & Barth, R. J. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001993 · Cited by 881
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Shehab, N., Lovegrove, M. C., Geller, A. I., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2016) · JAMA · doi:10.1001/jama.2016.16201 · Cited by 664
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N. S., Sethna, N. F., Kaur, S., & Mullington, J. M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 696
The Burden of Opioid-Related Mortality in the United States
Gomes, T., Tadrous, M., Mamdani, M., Paterson, J. M., & Juurlink, D. N. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0217 · Cited by 662
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
Peters, P. J., Pontones, P. R., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515195 · Cited by 598
Brat, G. A., Agniel, D., Beam, A., Yorkgitis, B., Bicket, M., Homer, M., Fox, K. P., Knecht, D. B., McMahill-Walraven, C. N., Palmer, N., et al. (2018) · BMJ · doi:10.1136/bmj.j5790 · Cited by 591
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
Zilverstand, A., Huang, A., Alia‐Klein, N., & Goldstein, R. Z. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.048 · Cited by 598
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
A review: Fentanyl and non-pharmaceutical fentanyls.
Suzuki, J., & Haddad, S. E. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 420
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 429
“The overall decrease in opioid use patterns, and the decision by the DEA to reduce the production of opioids, shows that both guidelines and regulations have had a significant effect on opioid dispensing, which seems to be reduced by 25% (139,140).”
BackgroundResultInfluentialAbuse and Misuse of Pregabalin and Gabapentin
Evoy, K. E., Morrison, M. D., & Saklad, S. R. (2017) · Drugs · doi:10.1007/s40265-017-0700-x · Cited by 411
Bohnert, A. S. B., Guy, G. P., & Losby, J. L. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1243 · Cited by 420
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643e1 · Cited by 388
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R. A., Simmons, S., Glick, R. M., Ratner, E. F., Lemmon, R., Wayne, P. M., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 404
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 443
Naloxone dosage for opioid reversal: current evidence and clinical implications
Lynn, R. R., & Galinkin, J. L. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617744161 · Cited by 363
Kelly, J. F., Bergman, B. G., Hoeppner, B. B., Vilsaint, C. L., & White, W. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.028 · Cited by 378
Morgan, J. R., Schackman, B. R., Leff, J. A., Linas, B. P., & Walley, A. Y. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.001 · Cited by 332
Treatment utilization among persons with opioid use disorder in the United States
Wu, L.-T. T., Zhu, H., & Swartz, M. S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.015 · Cited by 340
“Heroin use also accounted for recent major increases in opioid overdose deaths (Rudd et al., 2016).”
InfluentialFatal and nonfatal overdose among pregnant and postpartum women in Massachusetts
Schiff, D. M., Nielsen, T., Terplan, M., Hood, M., Bernson, D., Diop, H., Bharel, M., Wilens, T. E., LaRochelle, M., Walley, A. Y., et al. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002734 · Cited by 327
Alpert, A. E., Powell, D., & Pacula, R. L. (2018) · American Economic Journal Economic Policy · doi:10.1257/pol.20170082 · Cited by 326
Levitsky, J., Formica, R. N., Bloom, R. D., Charlton, M., Curry, M. P., Friedewald, J. J., Friedman, J. L., Goldberg, D. S., Hall, S. A., Ison, M. G., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14381 · Cited by 328
Peiper, N. C., Clarke, S. D., Vincent, L. B., Ciccarone, D., Kral, A. H., & Zibbell, J. E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.08.007 · Cited by 317
“, deaths from drug overdose, alcohol-related disease, and suicide) in states hard hit by the opioid epidemic (Case & Deaton, 2017; Diez Roux, 2017; Rudd et al., 2016; Zibbell et al., 2017).”
BackgroundUS National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016
Gaither, J. R., Shabanova, V., & Leventhal, J. M. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6558 · Cited by 321
Macroeconomic conditions and opioid abuse
Hollingsworth, A. J., Ruhm, C. J., & Simon, K. I. (2017) · Journal of Health Economics · doi:10.1016/j.jhealeco.2017.07.009 · Cited by 307
Patrick, S. W., Fry, C., Jones, T. F., & Buntin, M. B. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1496 · Cited by 301
Goedel, W. C., Shapiro, A. M., Cerdá, M., Tsai, J. W., Hadland, S. E., & Marshall, B. D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3711 · Cited by 310
Hadland, S. E., Wharam, J. F., Schuster, M. A., Zhang, F., Samet, J. H., & Larochelle, M. R. (2017) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.0745 · Cited by 295
Ending the Opioid Epidemic — A Call to Action
Murthy, V. H. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1612578 · Cited by 294
Prescription Opioid Use among Adults with Mental Health Disorders in the United States
Davis, M. A., Lin, L. A., Liu, H., & Sites, B. D. (2017) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2017.04.170112 · Cited by 270
Rate and Risk Factors Associated With Prolonged Opioid Use After Surgery
Lawal, O. D., Gold, J. L., Murthy, A., Ruchi, R., Bavry, E., Hume, A. L., Lewkowitz, A. K., Brothers, T. N., & Wen, X. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7367 · Cited by 301
Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury
Hsu, J. R., Mir, H. R., Wally, M. K., & Seymour, R. B. (2019) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001430 · Cited by 297
Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’
Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.004 · Cited by 291
Fairbairn, N. S., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 288
Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0448 · Cited by 264
Wakeman, S. E., Metlay, J. P., Chang, Y., Herman, G. E., & Rigotti, N. A. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4077-z · Cited by 262
Haffajee, R. L., Lin, L. A., Bohnert, A. S. B., & Goldstick, J. E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6373 · Cited by 266
Opioid-overdose laws association with opioid use and overdose mortality
McClellan, C. B., Lambdin, B. H., Ali, M. M., Mutter, R. L., Davis, C. S., Wheeler, E., Pemberton, M. R., & Kral, A. H. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.03.014 · Cited by 267
The Emergence of a Circuit Model for Addiction
Lüscher, C. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-013920 · Cited by 270
Schieber, L. Z., Guy, G. P., Seth, P., Young, R., Mattson, C. L., Mikosz, C. A., & Schieber, R. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0665 · Cited by 257
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
Haffajee, R. L., Bohnert, A. S. B., & Lagisetty, P. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.12.022 · Cited by 257
“Also under the ACA, plans are required to cover ten essential health benefits (EHBs), including: (1) mental health and substance use disorder services, and (2) a prescription drug Haffajee et al.”
BackgroundInfluentialShiels, M. S., Chernyavskiy, P., Anderson, W. F., Best, A. F., Haozous, E. A., Hartge, P. A., Rosenberg, P. S., Thomas, D. A., Freedman, N. D., & de González, A. B. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30187-3 · Cited by 252
Samples, H., Williams, A. R., Olfson, M., & Crystal, S. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.09.001 · Cited by 246
Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.023 · Cited by 230
Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare?
McLellan, A. T. (2017) · Europe PMC (PubMed Central) · Cited by 222
Surveillance for Violent Deaths — National Violent Death Reporting System, 32 States, 2016
Ertl, A. M., Sheats, K. J., Petrosky, E. Y., Betz, C. J., Yuan, K., & Fowler, K. A. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss.6809a1 · Cited by 217
“Opioid overdose has been recognized as an epidemic (35).”
BackgroundAssociation Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses
Fink, D. S., Schleimer, J. P., Sarvet, A. L., Grover, K. K., Delcher, C., Castillo‐Carniglia, Á., Kim, J. H., Rivera‐Aguirre, A., Henry, S. G., Martins, S. S., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3074 · Cited by 218
Trends in Black and White Opioid Mortality in the United States, 1979–2015
Alexander, M. J., Kiang, M. V., & Barbiéri, M. (2018) · Epidemiology · doi:10.1097/ede.0000000000000858 · Cited by 206
Chronic pain and opioid misuse: a review of reviews
Voon, P., Karamouzian, M., & Kerr, T. H. (2017) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-017-0120-7 · Cited by 212
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States
Durand, C. M., Bowring, M. G., Thomas, A. G., Kucirka, L. M., Massie, A. B., Cameron, A. M., Desai, N. M., Sulkowski, M., & Segev, D. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2451 · Cited by 206
Drivers of the fatal drug epidemic
Ruhm, C. J. (2019) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.01.001 · Cited by 190
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study
Kalkman, G. A., Kramers, C., van Dongen, R. T., van den Brink, W., & Schellekens, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30128-8 · Cited by 204
A conceptual model for understanding post-release opioid-related overdose risk
Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0145-5 · Cited by 208
Opioid Use Disorder in Pregnancy
Krans, E. E., & Patrick, S. W. (2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001446 · Cited by 192
Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality
Chenaf, C., Kaboré, J., Delorme, J., Pereira, B., Mulliez, A., Zénut, M., Delage, N., Ardid, D., Eschalier, A., & Authier, N. (2018) · European Journal of Pain · doi:10.1002/ejp.1291 · Cited by 203
“together with the 1950% increase in oxycodone use, authorities should be prompted to closely monitor this sharp rise, since oxycodone was one of the most common drugs involved in PO overdose deaths in the USA (Rudd et al., 2016).”
BackgroundLatimore, A. D., & Bergstein, R. S. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.09.010 · Cited by 189
Psychedelics: Where we are now, why we got here, what we must do
Belouin, S. J., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.018 · Cited by 218
Use of rapid fentanyl test strips among young adults who use drugs
Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.09.009 · Cited by 192
Garcia‐Romeu, A., Cox, D. J., Smith, K. E., Dunn, K. E., & Griffiths, R. R. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107849 · Cited by 187
Goldman, J. A., Waye, K. M., Periera, K. A., Krieger, M. S., Yedinak, J. L., & Marshall, B. D. L. (2019) · Harm Reduction Journal · doi:10.1186/s12954-018-0276-0 · Cited by 192
Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans
Lin, L. A., Bohnert, A. S. B., Kerns, R. D., Clay, M. A., Ganoczy, D. A., & Ilgen, M. A. (2017) · Pain · doi:10.1097/j.pain.0000000000000837 · Cited by 183
“in opioid-related outcomes, may, on average, have more modest effects overall.(25) The OSI was associated with significant reductions in highdosage opioid and concurrent benzodiazepines specifically in the large subgroup receiving opioids chronically.”
BackgroundCurrent perspectives on the opioid crisis in the US healthcare system
Stoicea, N., Costa, A. P., Periel, L., Uribe, A. A., Weaver, T. E., & Bergese, S. D. (2019) · Medicine · doi:10.1097/md.0000000000015425 · Cited by 182
Dowell, D., Arias, E., Kochanek, K. D., Anderson, R. N., Guy, G. P., Losby, J. L., & Baldwin, G. T. (2017) · JAMA · doi:10.1001/jama.2017.9308 · Cited by 184
Post-Discharge Opioid Prescribing and Use after Common Surgical Procedure
Fujii, M. H., Hodges, A., Russell, R. L., Roensch, K., Beynnon, B. D., Ahern, T. P., Holoch, P. A., Moore, J., Ames, E., & MacLean, C. D. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.01.058 · Cited by 177
“Introduction The number of deaths from prescription opioids in the United States continues to increase (1) and remains a major public health concern despite evidence that preventative measures and more conservative prescribing efforts can curtail this trend (2).”
Annual Summary of Vital Statistics: 2013–2014
Murphy, S. L., Mathews, T. J., Martin, J. A., Minkovitz, C. S., & Strobino, D. M. (2017) · PEDIATRICS · doi:10.1542/peds.2016-3239 · Cited by 176
Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids
Jones, C. M., Baldwin, G. T., & Compton, W. M. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303627 · Cited by 175
Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo, B. (2016) · Addiction · doi:10.1111/add.13741 · Cited by 174
The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain?
Yang, J., Bauer, B. A., Wahner‐Roedler, D. L., Chon, T. Y., & Xiao, L. (2020) · Journal of Pain Research · doi:10.2147/jpr.s244173 · Cited by 192
Barocas, J. A., White, L. F., Wang, J., Walley, A. Y., LaRochelle, M. R., Bernson, D., Land, T., Morgan, J. R., Samet, J. H., & Linas, B. P. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304673 · Cited by 164
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero‐Miller, J. D., & Huestis, M. A. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx031 · Cited by 166
Fleischauer, A. T., Ruhl, L. J., Rhea, S. K., & Barnes, E. W. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6622a1 · Cited by 165
“Furthermore, CDC estimated a near quadrupling of heroin-related overdose deaths during 2002–2014 (3).”
BackgroundRockett, I. R. H., Caine, E. D., Connery, H. S., D’Onofrio, G., Gunnell, D., Miller, T. R., Nolte, K. B., Kaplan, M. S., Kapusta, N. D., Lilly, C. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190200 · Cited by 166
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
Sharma, A., Kelly, S. M., Mitchell, S. G., Gryczynski, J., O’Grady, K. E., & Schwartz, R. P. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0783-9 · Cited by 163
Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review
Park, J.-Y., & Wu, L.-T. T. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.03.009 · Cited by 161
A Review of the Opioid Epidemic: What Do We Do About It?
Shipton, E. A., Shipton, A. J., & Shipton, A. J. (2018) · Pain and Therapy · doi:10.1007/s40122-018-0096-7 · Cited by 167
Jani, M., Yimer, B. B., Sheppard, T., Lunt, M., & Dixon, W. G. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003270 · Cited by 162
“Opioids have now become the leading cause of accidental death and unintentional injury in the US [4].”
BackgroundTrends in heroin and pharmaceutical opioid overdose deaths in Australia
Roxburgh, A., Hall, W., Dobbins, T., Gisev, N., Burns, L., Pearson, S., & Degenhardt, L. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.018 · Cited by 159
Trends in Opioid Utilization Before and After Total Knee Arthroplasty
Politzer, C. S., Kildow, B. J., Goltz, D. E., Green, C. L., Bolognesi, M. P., & Seyler, T. M. (2017) · The Journal of Arthroplasty · doi:10.1016/j.arth.2017.10.060 · Cited by 160
Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know
Kerensky, T., & Walley, A. Y. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0068-3 · Cited by 166
Prescription opioid exposures among children and adolescents in the United States: 2000–2015.
Allen, J. D., Casavant, M. J., Spiller, H. A., Chounthirath, T., Hodges, N. L., & Smith, G. A. (2017) · Pediatrics · doi:10.1542/peds.2016-3382 · Cited by 156
Garcia‐Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00955 · Cited by 171
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Wiese, B. M., & Wilson‐Poe, A. R. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0022 · Cited by 156
Geographic variation in opioid and heroin involved drug poisoning mortality rates
Ruhm, C. J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.009 · Cited by 152
Ali, M. M., Dowd, W. N., Classen, T., Mutter, R., & Novak, S. P. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.01.011 · Cited by 153
Zoorob, M. J., & Salemi, J. L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.12.011 · Cited by 155
Primary care models for treating opioid use disorders: What actually works? A systematic review
Lagisetty, P., Klasa, K., Bush, C. A., Heisler, M., Chopra, V., & Bohnert, A. S. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186315 · Cited by 155
Dwyer‐Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Shirude, S., Unützer, J., Naghavi, M., Mokdad, A. H., & Murray, C. J. L. (2018) · JAMA · doi:10.1001/jama.2018.0900 · Cited by 154
Evaluating the impact of prescription drug monitoring program implementation: a scoping review
Finley, E. P., Garcia, A., Rosen, K. D., McGeary, D., Pugh, M. J., & Potter, J. S. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2354-5 · Cited by 152
Trade Liberalization and Mortality: Evidence from U.S. Counties
Pierce, J. R., & Schott, P. K. (2016) · National Bureau of Economic Research · doi:10.3386/w22849 · Cited by 160
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study
Noller, G., Frampton, C. M., & Yazar‐Klosinski, B. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1310218 · Cited by 170
McDonald, R., CAMPBELL, N. D., & Strang, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.001 · Cited by 147
Opioids depress breathing through two small brainstem sites
Bachmutsky, I., Wei, X. P., Kish, E., & Yackle, K. (2020) · eLife · doi:10.7554/elife.52694 · Cited by 149
“This epidemic is not unique to the United States and 35 with the increasing distribution of highly potent synthetic opioids like fentanyl, it has become a 36 global public health emergency (2).”
Armenian, P., Olson, A., Anaya, A., Kurtz, A. M., Ruegner, R., & Gerona, R. R. L. (2016) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2016.06.014 · Cited by 147
“INTRODUCTION Since 2008, poisonings have been the leading cause of injury death in the United States, with the majority of these cases caused by opioid analgesics.(1) As the use and misuse of prescription opioid analgesics have increased, so have outbreaks of morbidity and mortality from synthetic opioids.”
BackgroundExplaining recent mortality trends among younger and middle-aged White Americans
Masters, R. K., Tilstra, A. M., & Simon, D. H. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx127 · Cited by 143
Dezfulian, C., Orkin, A. M., Maron, B. A., Elmer, J., Girotra, S. R., Gladwin, M. T., Merchant, R. M., Panchal, A. R., Perman, S. M., Starks, M. A., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000958 · Cited by 151
Chen, E. Y., Marcantonio, A., & Tornetta, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.4859 · Cited by 144
Metadata
- Authors
- Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M.
- Affiliations
- National Center for Injury Prevention and Control (US)
- Venue
- MMWR Morbidity and Mortality Weekly Report
- Published
- 2016-01-01
- Volume
- 64
- Issue
- 50-51
- Pages
- 1378-1382
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2292748019
- Cited by
- 1,859
- References
- 10
- Citations by year
- 2026: 16 · 2025: 35 · 2024: 42 · 2023: 79 · 2022: 118 · 2021: 144 · 2020: 242 · 2019: 271 · 2018: 332 · 2017: 406 · 2016: 169
- FWCI
- 321.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- drug overdose deaths, opioid overdose deaths, opioid epidemic, heroin, illicitly manufactured fentanyl, synthetic opioids, methadone, mortality trends, age-adjusted death rates, opioid use disorder, opioid supply
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Opioid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, United States, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review